RecruitingPhase 2NCT07509047

Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children

Studying Cholera

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
International Vaccine Institute
Principal Investigator
Julia Lynch, MD
International Vaccine Institute
Intervention
OSP:rTTHc CCV 25 ㎍ with Aluminum phosphate(biological)
Enrollment
390 target
Eligibility
1-45 years · All sexes
Timeline
2026 – 2027

Study locations (1)

Collaborators

EuBiologics Co.,Ltd · Massachusetts General Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07509047 on ClinicalTrials.gov

Other trials for Cholera

Additional recruiting or active studies for the same condition.

See all trials for Cholera →

← Back to all trials